HOT TOPIC Discussion: COVID-19 Vaccines, PrEP, MSM – What You Need to Know Heading Into 2021 (21EL-601) - Free for AABB Individual Members!

Please note: AABB reserves the right to make updates to this program.

Live Program Date: Thursday, January 7, 2021 - On-Demand Available

Program Number: 21EL-601


This hot topic discussion is provided complimentary to AABB individual members; nonmembers to pay $69. Group Viewing registration is not provided. After registering, access is granted via the AABB Education platform (after logging in using your AABB username and password simply click “My Learning Programs” and then “Hot Topic Discussions”). Please note: if you registered for the live program you do not need to register for this on-demand hot topic discussion (access to the on-demand hot topic discussion was included with the live program registration).

If you would like to receive this program for free as well as other great benefits consider joining AABB today.

  • Educational Track: Technical/Clinical
  • Topics: Blood Donation & Collection, Component Processing, COVID-19, Donation, Donation Process, Donor Eligibility, FDA, Infectious Diseases, Management Operations, Patient Transfusion, Regulatory & Compliance, Testing, Transfusion Safety
  • Intended Audience: COOs, Directors, Donor Recruitment Staff, Hospital Blood Banks, Hospitals, Laboratory Staff, Managers/Supervisors, Medical Directors, Nurses, Residents/Fellows, Students (MD, MT, SBB), Technologists, Transfusion Safety Officers
  • Teaching Level: Basic, Intermediate
  • Moderator: Sharon Carayiannis, BSMT(ASCP)HP, Senior Director, Regulatory Affairs, AABB

    • Jed B. Gorlin, MD, MBA, Innovative Blood Resources
    • Brian Custer, PhD, MPH, Vitalant Research Institute
    • Peter Marks, MD, PhD, Director, Center for Biologics Evaluation and Research, Food & Drug Administration
  • Program Description

    Join us for an exciting discussion addressing key donor eligibility considerations as we head into 2021. First Dr. Jed Gorlin will outline considerations and strategies around the impact of COVID-19 vaccines on blood donation, including convalescent plasma donors. Then Dr. Brian Custer will provide a summary and next step for practices around HIV detection in the ART/PrEP era. Finally, Dr. Peter Marks will provide an update on the agency’s MSM deferral policies and current studies. Presentations will be followed by an engaging Q&A period where speakers will field questions from the audience. Sharon Carayiannis, AABB Sr. Director of Regulatory Affairs, will moderate the session.

    Learning Objectives

    After participating in this educational activity, participants should be able to:

    • Consider the impact of COVID-19 vaccines on blood donation and options for updating donor deferral policies.
    • Discuss the latest research on the impact of ART and PrEP on HIV detection in blood donors and donor deferrals.
    • Discuss the FDA’s approach to MSM donor deferrals and future studies to inform policy decisions.

    Continuing Education Credit

    AABB designates both the live and on-demand version of this program each to be eligible for 1.25 continuing education credits/contact hours for Physicians, California Nurse, California Lab Personnel, Florida Lab Personnel and General Participation credit. The final number of credit(s) and credit types awarded for this program (live or on-demand) was determined by the program duration. For more information on each credit type please visit our Continuing Education Credits webpage.

    Disclosures for the planners of this event can be found here. Disclosures for the program faculty are provided at the beginning of the program.